Encapsulation of low lipophilic and slightly water-soluble dihydroartemisinin in PLGA nanoparticles with phospholipid to enhance encapsulation efficiency and in vitro bioactivity

References

• Ansari MT, Sunderland VB. Solid dispersions of dihydroartemisinin in polyvinylpyrrolidone. Arch Pharm Res, 2008;31:390–8.
   PubMed Web of Science ®Google Scholar
• Binh TQ, Ilett KF, Batty KT, Davis TM, Hung NC, Powell SM, Thu LT, Thien HV, Phuong HL, Phuong VD. Oral bioavailability of dihydroartemisinin in Vietnamese volunteers and in patients with falciparum malaria. Br J Clin Pharmacol, 2001;51:541–6.
   PubMed Web of Science ®Google Scholar
• Cai X, Luan Y, Jiang Y, Song A, Shao W, Li Z, Zhao Z. Huperzine A-phospholipid complex-loaded biodegradable thermosensitive polymer gel for controlled drug release. Int J Pharm, 2012;433:102–11.
   PubMed Web of Science ®Google Scholar
• Chen T, Li M, Zhang R, Wang H. Dihydroartemisinin induces apoptosis and sensitizes human ovarian cancer cells to carboplatin therapy. J Cell Mol Med, 2009;13:1358–70.
   PubMed Web of Science ®Google Scholar
• Cui F, Shi K, Zhang L, Tao A, Kawashima Y. Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: Preparation, in vitro characterization and in vivo evaluation. J Control Release, 2006;114:242–50.
   PubMed Web of Science ®Google Scholar
• Duncan R. Polymer conjugates as anticancer nanomedicines. Nature Rev Cancer, 2006;6:688–701.
   PubMed Web of Science ®Google Scholar
• Gan L. 2007. Study on the regularity in preparing PLGA nanoparticles loading different drugs. Chengdu, China: University of Sichuan.
   Google Scholar
• Harush-Frenkel O, Debotton N, Benita S, Altschuler Y. Targeting of nanoparticles to the clathrin-mediated endocytic pathway. Biochem Biophys Res Commun, 2007;353:26–32.
   PubMed Web of Science ®Google Scholar
• Hou J, Wang D, Zhang R, Wang H. Experimental therapy of hepatoma with artemisinin and its derivatives: In vitro and in vivo activity, chemosensitization, and mechanisms of action. Clin Cancer Res, 2008;14:5519–30.
   PubMed Web of Science ®Google Scholar
• Huang M, Lu JJ, Huang MQ, Bao JL, Chen XP, Wang YT. Terpenoids: Natural products for cancer therapy. Expert Opin Invest Drugs, 2012;21:1801–18.
   PubMed Web of Science ®Google Scholar
• Jena SK, Singh C, Dora CP, Suresh S. Development of tamoxifen-phospholipid complex: Novel approach for improving solubility and bioavailability. Int J Pharm, 2014;47:31–9.
   Google Scholar
• Kumari A, Yadav SK, Yadav SC. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B, Biointerfaces, 2010;75:1–18.
   PubMed Web of Science ®Google Scholar
• Langer R. Drug delivery and targeting. Nature, 1998;392:5–10.
   PubMed Web of Science ®Google Scholar
• Leo E, Brina B, Forni F, Vandelli MA. In vitro evaluation of PLA nanoparticles containing a lipophilic drug in water-soluble or insoluble form. Int J Pharm, 2004;278:133–41.
   PubMed Web of Science ®Google Scholar
• Li L, Dong W, Xia X, Li Y, Liu Y. Preparation, formation mechanism and preliminary evaluation of oral absorption of a bicyclol-phospholipid complex. Acta Pharm Sin, 2014;49:1600–6.
   Google Scholar
• Liu J, Gong T, Wang C, Zhong Z, Zhang Z. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: Preparation and characterization. Int J Pharm, 2007;340:153–62.
   PubMed Web of Science ®Google Scholar
• Lu JJ, Chen SM, Zhang XW, Ding J, Meng LH. The anti-cancer activity of dihydroartemisinin is associated with induction of iron-dependent endoplasmic reticulum stress in colorectal carcinoma HCT116 cells. Invest New Drugs, 2011;29:1276–83.
   PubMed Web of Science ®Google Scholar
• Lu JJ, Meng LH, Shankavaram UT, Zhu CH, Tong LJ, Chen G, Lin LP, Weinstein JN, Ding J. Dihydroartemisinin accelerates c-MYC oncoprotein degradation and induces apoptosis in c-MYC-overexpressing tumor cells. Biochem Pharmacol, 2010;80:22–30.
   PubMed Web of Science ®Google Scholar
• Luo D. Identification of structure and antioxidant activity of a fraction of polysaccharide purified from Dioscorea nipponica Makino. Carbohydr Polym, 2008;71:544–9.
   Web of Science ®Google Scholar
• Ma Y, Zhao X, Li J, Shen Q. The comparison of different daidzein-PLGA nanoparticles in increasing its oral bioavailability. Int J Nanomedicine, 2012;7:559–70.
   PubMed Web of Science ®Google Scholar
• Peng Q, Gong T, Zuo J, Liu J, Zhao D, Zhang Z. Enhanced oral bioavailability of salvianolic acid B by phospholipid complex loaded nanoparticles. Pharmazie, 2008;63:661–6.
   PubMed Web of Science ®Google Scholar
• Peng Q, Zhang ZR, Gong T, Chen GQ, Sun X. A rapid-acting, long-acting insulin formulation based on a phospholipid complex loaded PHBHHx nanoparticles. Biomaterials, 2012;33:1583–8.
   PubMed Web of Science ®Google Scholar
• Peng Q, Zhang ZR, Sun X, Zuo J, Zhao D, Gong T. Mechanisms of phospholipid complex loaded nanoparticles enhancing the oral bioavailability. Mol Pharm, 2010;7:565–75.
   PubMed Web of Science ®Google Scholar
• Tan Q, Liu S, Chen X, Wu M, Wang H, Yin H, He D, Xiong H, Zhang J. Design and evaluation of a novel evodiamine-phospholipid complex for improved oral bioavailability. AAPS PharmSciTech, 2012;13:534–47.
   PubMed Web of Science ®Google Scholar
• Tewes F, Munnier E, Antoon B, Ngaboni Okassa L, Cohen-Jonathan S, Marchais H, Douziech-Eyrolles L, Souce M, Dubois P, Chourpa I. Comparative study of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles prepared by single and double emulsion methods. Eur J Pharm Biopharm, 2007;66:488–92.
   PubMed Web of Science ®Google Scholar
• Wang SJ, Gao Y, Chen H, Kong R, Jiang HC, Pan SH, Xue DB, Bai XW, Sun B. Dihydroartemisinin inactivates NF-kappaB and potentiates the anti-tumor effect of gemcitabine on pancreatic cancer both in vitro and in vivo. Cancer Lett, 2010;293:99–108.
   PubMed Web of Science ®Google Scholar
• Wu GS, Lu JJ, Guo JJ, Huang MQ, Gan L, Chen XP, Wang YT. Synergistic anti-cancer activity of the combination of dihydroartemisinin and doxorubicin in breast cancer cells. Pharmacol Rep, 2013;65:453–9.
   PubMed Web of Science ®Google Scholar
• Xiao Y, Song Y, Chen Z, Ping Q. The preparation of silybin-phospholipid complex and the study on its pharmacokinetics in rats. Int J Pharm, 2006;307:77–82.
   PubMed Web of Science ®Google Scholar
• Yeo Y, Park K. Control of encapsulation efficiency and initial burst in polymeric microparticle systems. Arch Pharm Res, 2004;27:1–12.
   PubMed Web of Science ®Google Scholar
• Yoo HS, Choi HK, Park TG. Protein-fatty acid complex for enhanced loading and stability within biodegradable nanoparticles. J Pharmaceut Sci, 2001;90:194–201.
   PubMed Web of Science ®Google Scholar
• Yoo HS, Park TG. Biodegradable nanoparticles containing protein-fatty acid complexes for oral delivery of salmon calcitonin. J Pharmaceut Sci, 2004;93:488–95.
   PubMed Web of Science ®Google Scholar
• Yue PF, Yuan HL, Li XY, Yang M, Zhu WF. Process optimization, characterization and evaluation in vivo of oxymatrine-phospholipid complex. Int J Pharm, 2010;387:139–46.
   PubMed Web of Science ®Google Scholar
• Zhang CZ, Zhang H, Yun J, Chen GG, Lai PB. Dihydroartemisinin exhibits antitumor activity toward hepatocellular carcinoma in vitro and in vivo. Biochem Pharmacol, 2012;83:1278–89.
   PubMed Web of Science ®Google Scholar
• Zhang J, Li Y, Gao W, Repka MA, Wang Y, Chen M. Andrographolide-loaded PLGA-PEG-PLGA micelles to improve its bioavailability and anticancer efficacy. Expert Opin Drug Deliv, 2014;11:1367–80.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhao P, Qiao H, Ni J, Shi Y. Study on dihydroartemisinin phospholipid complex. Chin J Mod Appl Pharm, 2013;30:636–41.
   Google Scholar
• Zhou H, Wan J, Wu L, Yi T, Liu W, Xu H, Yang X. A new strategy for enhancing the oral bioavailability of drugs with poor water-solubility and low liposolubility based on phospholipid complex and supersaturated SEDDS. PLoS One, 2013;8:e84530.
   PubMed Web of Science ®Google Scholar
• Zhou HJ, Zhang JL, Li A, Wang Z, Lou XE. Dihydroartemisinin improves the efficiency of chemotherapeutics in lung carcinomas in vivo and inhibits murine Lewis lung carcinoma cell line growth in vitro. Cancer Chemother Pharmacol, 2010;66:21–9.
   PubMed Web of Science ®Google Scholar
• Zhu H, Liao SD, Shi JJ, Chang LL, Tong YG, Cao J, Fu YY, Chen XP, Ying MD, Yang B, et al. DJ-1 mediates the resistance of cancer cells to dihydroartemisinin through reactive oxygen species removal. Free Radic Biol Med, 2014;71:121–32.
   PubMed Web of Science ®Google Scholar